Evocalcet with vitamin D receptor activator treatment for secondary hyperparathyroidism

• Takashi Shigematsu ,

  Roles Conceptualization, Writing – review & editing

  * E-mail: docteur_shigemat@iris.eonet.ne.jp

  Affiliation Department of Nephrology, Wakayama Medical University, Wakayama, Japan

  https://orcid.org/0000-0002-6330-3784

  ⨯
• Shinji Asada,

  Roles Data curation, Formal analysis, Investigation, Methodology, Writing – original draft

  Affiliation Medical Affairs Department, Kyowa Kirin Co., Ltd., Tokyo, Japan

  https://orcid.org/0000-0002-7717-8945

  ⨯
• Yuichi Endo,

  Roles Data curation, Formal analysis, Investigation, Methodology

  Affiliation R&D Division, Kyowa Kirin Co., Ltd., Tokyo, Japan

  ⨯
• Takehisa Kawata,

  Roles Data curation, Formal analysis, Investigation, Methodology, Writing – original draft

  Affiliation Medical Affairs Department, Kyowa Kirin Co., Ltd., Tokyo, Japan

  ⨯
• Masafumi Fukagawa,

  Roles Conceptualization, Writing – review & editing

  Affiliation Division of Nephrology, Endocrinology, and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan

  ⨯
• Tadao Akizawa

  Roles Conceptualization, Writing – review & editing

  Affiliation Division of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan

  ⨯